对８６例女性肺癌组织进行临床病理分型，雌激素受体（ＥＲ）及ＡＢＯ（Ｈ）抗原检测，并对其与手术预后的关系进行了分析。结果表明，女性肺腺癌所占比例，明显高于男性，女性肺鳞癌术后５年生存率，明显高于女性肺腺癌，而女性肺腺癌术后５年生存率，又明显低于男性。８０例进行ＥＲ检测，其结果５年生存率ＥＲ（—）者为７２．７％，ＥＲ（＋）者为８．８％，两者之间差异有非常显著意义（Ｐ＜０．０１）。２３例进行了ＡＢＯ（Ｈ）抗原的检测，其结果５年生存率ＡＢＯ（Ｈ）抗原（＋）者为７５％，抗原（—）者无生存病人，两者之间差异有显著意义（Ｐ＜０．０５）。提示女性肺癌病人的手术预后与其病理类型、ＥＲ及ＡＢＯ（Ｈ）抗原检测结果密切相关。 A total of 86 female lung cancer tissues were classified by clinicopathology, estrogen receptor (ER) and ABO (H) antigens, and their relationship with surgical outcomes was analyzed. The results showed that the proportion of female lung adenocarcinoma was significantly higher than that of males. The 5-year survival rate of female lung squamous cell carcinoma was significantly higher than that of female lung adenocarcinoma, and the 5-year survival rate of female lung adenocarcinoma was significantly lower. For men. 80 cases of ER detection, the results of 5-year survival rate of ER (-) was 72.7%, ER (+) were 8.8%, the difference between the two has very significant (P <0.01) . ABO (H) antigen detection was performed in 23 cases. The 5-year survival rate was 75% for ABO (H) antigen (+) patients, and there was no survival for patients with antigen (-). There was a significant difference between the two (P). <0.05). It is suggested that the surgical outcomes of female lung cancer patients are closely related to their pathological types, ER and ABO (H) antigen test results.